Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion to Myfortic for GI Symptoms in Kidney Transplant
NCT00239005Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Primary completion
- Mar 2008
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate sodium in kidney transplantation (2 arms), sponsored by Novartis. Primary endpoint: Mycophenolic Acid Maintenance Treatment at 13 weeks. Started Sep 2005; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00239005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239005.